Importantly, S1P-regulated parenchymatic and immune cells are driven into spaces of cells with active inflammation, which delays the pathogenesis of hepatitis; therefore, S1P may constitute the potential target for the treatment of simple steatosis and its deterioration to active steatotic-related inflammation [26]. The gene discussed is MBTPS1; the disease is hepatitis A virus infection.